MiR Scientific Prepares to Launch Prostate Cancer, Bladder Cancer Tests - GenomeWeb

NEW YORK (GenomeWeb) – After presenting initial validation data on a prostate cancer microRNA-based urine assay that is designed to aid diagnosis, provide prognosis, and monitor disease progression, MiR Scientific believes it is prepared to launch tests for both bladder and prostate cancer by the end of this year or early next.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.



https://ift.tt/2YstjPj

Comments

Popular posts from this blog

I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...

Early symptoms of cancer in males: Common warning signs

20 Famous Men Who Have Had Prostate Cancer